Contemporary Sarcoma Diagnosis, Genetics, and Genomics The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated.
For patients with challenging cancers like lymphoma and sarcoma, subtle genetic differences can dramatically change the way doctors diagnose and treat their disease. There are more than 70 recognized ...
SAN FRANCISCO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the commercial launch of Paragon, a solid tumor ...
Soft tissue sarcomas are a rare and often hard-to-treat group of cancers that typically require a combination of surgery, radiation therapy and other systemic treatments. However, these tumors may ...
This workshop explored current and potential future applications for AI in genomics and precision health along the continuum from translational research to clinical applications. A planning committee ...
Sarcoma originates in connective tissues, with soft tissue and bone sarcomas as primary categories, each having multiple subtypes. Staging considers tumor size, grade, and metastasis, guiding ...
Today marks the PDUFA date for Cambridge, Mass.-based Epizyme Inc.’s tazemetostat. The FDA has granted priority review for the NDA related to the EZH2 inhibitor, and in December, members of the agency ...
Contemporary Sarcoma Diagnosis, Genetics, and Genomics The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results